Utilization of Colistin for Treatment of Multidrug-Resistant Pseudomonas aeruginosa
BACKGROUND: Colistin is uncommonly used in clinical practice; however, the emergence of multidrug-resistant organisms has rekindled interest in this potentially toxic therapeutic option. The present study describes the authors’ experience with colistin in the management of patients who were infected...
Saved in:
Main Authors: | Deana M Sabuda, Kevin Laupland, Johann Pitout, Bruce Dalton, Harvey Rabin, Thomas Louie, John Conly |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2008/743197 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ceftazidime-Avibactam Versus Colistin for the Treatment of Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Infections: A Multicenter Cohort Study
by: Thamer A. Almangour, et al.
Published: (2025-01-01) -
Multidrug resistance of Pseudomonas aeruginosa: do virulence properties impact on resistance patterns?
by: Poulomi Saha, et al.
Published: (2025-02-01) -
Antimicrobial resistance, virulence gene profiling, and genetic diversity of multidrug-resistant Pseudomonas aeruginosa isolates in Mazandaran, Iran
by: Ghazaleh Elahi, et al.
Published: (2024-12-01) -
Mutant Prevention Concentrations of Doripenem and Meropenem Alone and in Combination with Colistin (Polymyxin E), Levofloxacin and Tobramycin in Pseudomonas aeruginosa
by: George G Zhanel, et al.
Published: (2009-01-01) -
Essential oils modulate virulence phenotypes in a multidrug-resistant pyomelanogenic Pseudomonas aeruginosa clinical isolate
by: Jayalekshmi Haripriyan, et al.
Published: (2025-01-01)